4//SEC Filing
Wellinghoff Darryl 4
Accession 0000920465-20-000050
CIK 0000920465other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 4:03 PM ET
Size
7.0 KB
Accession
0000920465-20-000050
Insider Transaction Report
Form 4
Wellinghoff Darryl
Chief Commercial Officer
Transactions
- Award
Common Stock
2020-04-15$5.61/sh+34$191→ 9,504 total - Award
Stock Option (Right to Buy)
2020-04-15+34→ 34 totalExercise: $6.60Exp: 2030-04-15→ Common Stock (34 underlying)
Footnotes (2)
- [F1]These shares were acquired on 04/15/2020 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001770350
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 4:03 PM ET
- Size
- 7.0 KB